ADAM9 Expression is a Significant and Independent Prognostic Marker of PSA Relapse in Prostate Cancer-Reference-Cited by-同舟云学术

ADAM9 Expression is a Significant and Independent Prognostic Marker of PSA Relapse in Prostate Cancer

Published:2008-11 Issue:5 Volume:54 Page:1097-1108
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Fritzsche Florian R.,Jung Monika,Tölle Angelika,Wild Peter,Hartmann Arndt,Wassermann Kirsten,Rabien Anja,Lein Michael,Dietel Manfred,Pilarsky Christian,Calvano Daniela,Grützmann Robert,Jung Klaus,Kristiansen Glen

Publisher

Elsevier BV

Subject

Urology

Reference30 articles.

1. Meltrin gamma(ADAM-9) mediates cellular adhesion through alpha(6)beta(1)integrin, leading to a marked induction of fibroblast cell motility;Nath;J Cell Sci,2000

2. Cysteine-rich domain of human ADAM 12 (meltrin alpha) supports tumor cell adhesion;Iba;Am J Pathol,1999

3. Cloning and expression in Pichia pastoris of metalloprotease domain of ADAM 9 catalytically active against fibronectin;Schwettmann;Protein Expr Purif,2001

4. MDC-9 (ADAM-9/Meltrin gamma) functions as an adhesion molecule by binding the alpha(v)beta(5) integrin;Zhou;Biochem Biophys Res Commun,2001

5. Increased expression of ADAM family members in human breast cancer and breast cancer cell lines;Lendeckel;J Cancer Res Clin Oncol,2005

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the oncogenic and tumor-suppressive roles of Circ-ADAM9 in cancer;Pathology - Research and Practice;2024-04

2. The Potential of Extracellular Matrix- and Integrin Adhesion Complex-Related Molecules for Prostate Cancer Biomarker Discovery;Biomedicines;2023-12-28

3. The ADAM9/WISP-1 axis cooperates with osteoblasts to stimulate primary prostate tumor growth and metastasis;International Journal of Biological Sciences;2023

4. Preclinical Evaluation of IMGC936, a Next-Generation Maytansinoid-based Antibody–drug Conjugate Targeting ADAM9-expressing Tumors;Molecular Cancer Therapeutics;2022-05-05

5. Non-coding RNAs and glioblastoma: Insight into their roles in metastasis;Molecular Therapy - Oncolytics;2022-03